Rejected
at 6:58 p.m. Oct, 31, 2023 ]
by
Dam_Doc
Author:
jpk429
Type of change:
Other
Rationale for change
PTC = Papillary thyroid carcinoma
Card was redundant, BRAF is the actual mutation and fits better
Rejection reason
This is not correct. Both Braf AND RTC/RET mutations lead to Thyroid Papillary carcinoma. "The papillary thyroid carcinoma oncogene (RET/PTC) is a rearranged version of the tyrosine kinase RET, the receptor for glial-cell-line-derived neurotrophic factor. 13 RET/PTC rearrangement is nearly restricted to papillary thyroid carcinomas" The extra section even says as much.
Current
Suggested
Text
Text
Text
Text
Extra
- PTC = Papillary Thyroid Carcinoma
- RET/PTC rearrangements and BRAF mutations
Papillary thyroid carcinoma:


Photo credit: © Dr. Jian-Hua Qiao, all rights reserved, via Flickr (used with permission)
- RET/PTC rearrangements and BRAF mutations
Papillary thyroid carcinoma:


Photo credit: © Dr. Jian-Hua Qiao, all rights reserved, via Flickr (used with permission)
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy



Watch Thyroid Nodules & Cancer



Watch Thyroid Nodules & Cancer
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
OME
Additional Resources
Empty field
One by one
Empty field
